SCHEMBL30145295

SCHEMBL30145295

COc1ccc(-c2cccn3cc(CC(=O)O)nc23)c(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A3 P47895 3/20 0.43
▸ ALDH1A1 P00352 6/20 0.40
▸ KDM4E B2RXH2 5/20 0.40
▸ POLB P06746 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ EIF4E P06730 1/20 0.39
▸ PTGS1 P23219 1/20 0.39
▸ AKR1C3 P42330 1/20 0.39
▸ AKR1C2 P52895 1/20 0.39
▸ HSD17B10 Q99714 4/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ PPARG P37231 1/20 0.37
▸ HPGD P15428 3/20 0.37
▸ TP53 P04637 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30145217 0.91 ALDH1A3 (0.42) ALDH1A3ALDH1A1KDM4EEIF4EHSD17B10
SCHEMBL20596557 0.88 MAPT (0.43) ALDH1A3ALDH1A1KDM4EPOLBTDP1
SCHEMBL20596534 0.82 LMNA (0.39) ALDH1A3ALDH1A1KDM4EHSP90AA1HSP90AB1
SCHEMBL20596077 0.75 HSP90AA1 (0.39) ALDH1A1KDM4EPOLBEIF4EPTGS1
SCHEMBL30145317 0.74 MARS2 (0.44) ALDH1A1KDM4EPOLBTDP1L3MBTL1
SCHEMBL20595826 0.74 MARS2 (0.52) ALDH1A3HSP90AA1HSP90AB1PPARG
SCHEMBL30145166 0.74 MARS2 (0.52) ALDH1A3HSP90AA1HSP90AB1PPARG
SCHEMBL30145251 0.73 MARS2 (0.54) ALDH1A3HSP90AA1HSP90AB1PPARG
SCHEMBL20595977 0.73 MARS2 (0.54) ALDH1A3HSP90AA1HSP90AB1PPARG
SCHEMBL23419543 0.72 LMNA (0.36) ALDH1A1TDP1EIF4EPTGS1AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584744-B2 Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them UNIVERSITY OF WASHINGTON (US) 2023-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584744-B2 Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them AARS1, EMG1, GARS1 ALDH1A3 1695/4885ALDH1A1 1461/4885KDM4E 1618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback